Success of Big Infectious Disease Reimbursement Policy in China

Nie, Kun-xi; Wang, Chan; Li, Xin-wu

There are also some research works on predicting infectious disease using big data to control medical cost. 10, 11 Recently, some researchers suggested using medical reimbursement to solve the dispute between hospitals and patients and some other issues. [12] [13] [14] But very limited literature discussed about the reimbursement to cope with big infectious diseases in economics. Based on the successful experience of coping with SARS in 2003, this article resorts to the infectious disease model to capture the rationality of reimbursement in preventing big infectious diseases. The contribution of this article is to compare expenditures with government reimbursement and without government reimbursement, and this article finds the reimbursement policy to be successful in controlling expenditures. Therefore, it is necessary to launch full reimbursement policy for infectious diseases under high expenditures incurred by the treatment condition. The higher the treatment costs, the more important the government intervention.